Crossmark

Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan

Crossref DOI link: https://doi.org/10.1007/s43441-023-00566-6

Published Online: 2023-08-16

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aoi, Yoko

Kato, Yuta

Asano, Kunihito

Otsubo, Yasuto

Uyama, Yoshiaki https://orcid.org/0000-0002-0430-9887
Funding

Funding for this research was provided by:

Ministry of Health, Labour and Welfare (20KC2010)
License Information

Text and Data Mining valid from 2023-08-16

Version of Record valid from 2023-08-16
More Information

Article History

Received: 11 March 2023

Accepted: 28 July 2023

First Online: 16 August 2023

Declarations

:

: The authors declare no conflicts of interest in this study.

Document is current

Any future updates will be listed below